184 related articles for article (PubMed ID: 35653922)
1. Analysis of clinicopathological and molecular features of ELOC(TCEB1)-mutant renal cell carcinoma.
Wang Y; Zhao P; Wang L; Wang J; Ji X; Li Y; Shi H; Li Y; Zhang W; Jiang Y
Pathol Res Pract; 2022 Jul; 235():153960. PubMed ID: 35653922
[TBL] [Abstract][Full Text] [Related]
2. "Renal Cell Carcinoma With Leiomyomatous Stroma" Harbor Somatic Mutations of TSC1, TSC2, MTOR, and/or ELOC (TCEB1): Clinicopathologic and Molecular Characterization of 18 Sporadic Tumors Supports a Distinct Entity.
Shah RB; Stohr BA; Tu ZJ; Gao Y; Przybycin CG; Nguyen J; Cox RM; Rashid-Kolvear F; Weindel MD; Farkas DH; Trpkov K; McKenney JK
Am J Surg Pathol; 2020 May; 44(5):571-581. PubMed ID: 31850909
[TBL] [Abstract][Full Text] [Related]
3. Positive GPNMB Immunostaining Differentiates Renal Cell Carcinoma With Fibromyomatous Stroma Associated With TSC1/2/MTOR Alterations From Others.
Li H; Argani P; Halper-Stromberg E; Lotan TL; Merino MJ; Reuter VE; Matoso A
Am J Surg Pathol; 2023 Nov; 47(11):1267-1273. PubMed ID: 37661807
[TBL] [Abstract][Full Text] [Related]
4. [Clinicopathological and molecular genetic characteristics of ELOC mutated renal cell carcinoma].
Wen Z; Zhang WH; Liang JY; Chai J; Wang YM; Xu WN; Wang Z; Fan LN
Zhonghua Bing Li Xue Za Zhi; 2023 Dec; 52(12):1204-1209. PubMed ID: 38058035
[No Abstract] [Full Text] [Related]
5. [Clinicopathological characteristics of fumarate hydratase-deficient renal cell carcinoma].
Zhang W; Chu J; Zou YW; Jiang YX; Wei ZM; Zhong DC; Liu Y; Li YJ; Yu WJ
Zhonghua Bing Li Xue Za Zhi; 2019 Feb; 48(2):120-126. PubMed ID: 30695864
[No Abstract] [Full Text] [Related]
6. TCEB1-mutated renal cell carcinoma: a distinct genomic and morphological subtype.
Hakimi AA; Tickoo SK; Jacobsen A; Sarungbam J; Sfakianos JP; Sato Y; Morikawa T; Kume H; Fukayama M; Homma Y; Chen YB; Sankin A; Mano R; Coleman JA; Russo P; Ogawa S; Sander C; Hsieh JJ; Reuter VE
Mod Pathol; 2015 Jun; 28(6):845-853. PubMed ID: 25676555
[TBL] [Abstract][Full Text] [Related]
7. TSC/MTOR mutated renal cell carcinoma with leiomyomatous stroma is a distinct entity: a comprehensive study of 12 cases.
Tjota MY; Sharma A; Wanjari P; Fitzpatrick C; Segal J; Antic T
Hum Pathol; 2023 Apr; 134():124-133. PubMed ID: 36592877
[TBL] [Abstract][Full Text] [Related]
8. [Clinicopathological features and differential diagnosis of eosionphilic chromophobe renal cell carcinoma].
Zhang W; Song TT; He B; Wang H; Kang EH; Yu WJ; Zhong DC; Jiang YX; Li YJ
Zhonghua Bing Li Xue Za Zhi; 2020 Dec; 49(12):1242-1248. PubMed ID: 33287507
[No Abstract] [Full Text] [Related]
9. Renal Cell Carcinoma With Fibromyomatous Stroma-The Whole Story.
Shah RB
Adv Anat Pathol; 2022 May; 29(3):168-177. PubMed ID: 35249990
[TBL] [Abstract][Full Text] [Related]
10. [Acquired cystic kidney disease-associated renal cell carcinoma: a clinicopathologic study of three cases].
Zhang W; Xu LL; Yu WJ; Wang Q; Jiang YX; Liu Y; Li YJ
Zhonghua Bing Li Xue Za Zhi; 2018 May; 47(5):366-371. PubMed ID: 29783804
[No Abstract] [Full Text] [Related]
11. [Clinicopathologic features and differential diagnosis of multilocular cystic renal cell carcinoma].
Zhang W; Li Y; Lu Q; Zhuang J; Wang Q; Zhao H; Yu W; Kang E; Feng Z
Zhonghua Bing Li Xue Za Zhi; 2014 Nov; 43(11):723-7. PubMed ID: 25582248
[TBL] [Abstract][Full Text] [Related]
12. [Clear cell papillary renal cell carcinoma: a distinct low-grade renal tumour].
Yang X; Miao N; Gan H; Wang L; Wang C
Zhonghua Bing Li Xue Za Zhi; 2015 Jun; 44(6):372-6. PubMed ID: 26704829
[TBL] [Abstract][Full Text] [Related]
13. [Diagnostic utility of immunohistochemistry in differential diagnosis of renal tumors with oncocytic features].
Zhang W; Yu WJ; Chen YQ; Kang EH; Liu Y; Zhuang J; Jiang YX; Chu J; Li YJ
Zhonghua Bing Li Xue Za Zhi; 2016 Oct; 45(10):692-697. PubMed ID: 27760610
[No Abstract] [Full Text] [Related]
14. Biallelic ELOC-Inactivated Renal Cell Carcinoma: Molecular Features Supporting Classification as a Distinct Entity.
Batavia AA; Rutishauser D; Sobottka B; Schraml P; Beerenwinkel N; Moch H
Mod Pathol; 2023 Aug; 36(8):100194. PubMed ID: 37088333
[TBL] [Abstract][Full Text] [Related]
15. TFEB Rearranged Renal Cell Carcinoma: Pathological and Molecular Characterization of 10 Cases, with Novel Clinical Implications: A Single Center 10-Year Experience.
Wang AX; Tian T; Liu LB; Yang F; He HY; Zhou LQ
Biomedicines; 2023 Jan; 11(2):. PubMed ID: 36830782
[TBL] [Abstract][Full Text] [Related]
16. [Study on clinicopathologic features and immunophenotype of 114 cases of renal cell carcinoma].
Zou H; Pang LJ; Hu WH; Li F; Li HA; Jiang JF; Liang WH; Sun ZZ; Wang C; Lang JY
Zhonghua Bing Li Xue Za Zhi; 2008 Nov; 37(11):726-31. PubMed ID: 19094705
[TBL] [Abstract][Full Text] [Related]
17. Biphasic squamoid alveolar papillary renal cell carcinoma: A unique papillary renal cell carcinoma with distinctive morphology, immunophenotype and molecular genetic features.
Li Y; Wu X; Yang J; Jiang Y; Li Y; Zhang W; Yu W
Pathol Res Pract; 2022 Nov; 239():154120. PubMed ID: 36201928
[TBL] [Abstract][Full Text] [Related]
18. Clear cell-papillary renal cell carcinoma of the kidney not associated with end-stage renal disease: clinicopathologic correlation with expanded immunophenotypic and molecular characterization of a large cohort with emphasis on relationship with renal angiomyoadenomatous tumor.
Aron M; Chang E; Herrera L; Hes O; Hirsch MS; Comperat E; Camparo P; Rao P; Picken M; Michal M; Montironi R; Tamboli P; Monzon F; Amin MB
Am J Surg Pathol; 2015 Jul; 39(7):873-88. PubMed ID: 25970682
[TBL] [Abstract][Full Text] [Related]
19. Clear cell papillary renal cell carcinoma-like tumors in patients with von Hippel-Lindau disease are unrelated to sporadic clear cell papillary renal cell carcinoma.
Williamson SR; Zhang S; Eble JN; Grignon DJ; Martignoni G; Brunelli M; Wang M; Gobbo S; Baldridge LA; Cheng L
Am J Surg Pathol; 2013 Aug; 37(8):1131-9. PubMed ID: 23648463
[TBL] [Abstract][Full Text] [Related]
20. [Oncocytic papillary renal cell carcinoma: a clinicopathological analysis of nineteen cases].
Zhang W; Zhang LX; Yang T; Zou YW; Liu XL; Yu WJ; Jiang YX; Li YJ
Zhonghua Bing Li Xue Za Zhi; 2022 Oct; 51(10):981-986. PubMed ID: 36207910
[No Abstract] [Full Text] [Related]
[Next] [New Search]
